T. Rowe Price Associates’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
29,861
+12,325
| +70% | +$52.8K | ﹤0.01% | 2842 |
|
|
2025
Q1 | $66K | Sell |
17,536
-8,576
| -33% | -$32.3K | ﹤0.01% | 2892 |
|
|
2024
Q4 | $153K | Sell |
26,112
-5,346
| -17% | -$31.3K | ﹤0.01% | 2754 |
|
|
2024
Q3 | $376K | Buy |
31,458
+216
| +0.7% | +$2.58K | ﹤0.01% | 2375 |
|
|
2024
Q2 | $339K | Buy |
31,242
+4,991
| +19% | +$54.2K | ﹤0.01% | 2368 |
|
|
2024
Q1 | $298K | Buy |
26,251
+1,486
| +6% | +$16.9K | ﹤0.01% | 2435 |
|
|
2023
Q4 | $348K | Sell |
24,765
-14,081
| -36% | -$198K | ﹤0.01% | 2331 |
|
|
2023
Q3 | $480K | Sell |
38,846
-22,007
| -36% | -$272K | ﹤0.01% | 2118 |
|
|
2023
Q2 | $550K | Buy |
60,853
+2,553
| +4% | +$23.1K | ﹤0.01% | 2081 |
|
|
2023
Q1 | $203K | Sell |
58,300
-10,200
| -15% | -$35.5K | ﹤0.01% | 2520 |
|
|
2022
Q4 | $168K | Hold |
68,500
| – | – | ﹤0.01% | 2585 |
|
|
2022
Q3 | $190K | Hold |
68,500
| – | – | ﹤0.01% | 2558 |
|
|
2022
Q2 | $279K | Sell |
68,500
-2,372
| -3% | -$9.66K | ﹤0.01% | 2468 |
|
|
2022
Q1 | $302K | Buy |
70,872
+700
| +1% | +$2.98K | ﹤0.01% | 2537 |
|
|
2021
Q4 | $657K | Buy |
+70,172
| New | +$657K | ﹤0.01% | 2255 |
|
|
2021
Q3 | – | Sell |
-8,623
| Closed | -$241K | – | 2967 |
|
|
2021
Q2 | $241K | Buy |
8,623
+173
| +2% | +$4.84K | ﹤0.01% | 2653 |
|
|
2021
Q1 | $280K | Buy |
+8,450
| New | +$280K | ﹤0.01% | 2583 |
|